irinotecan hydrochloride trihydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial
AUST R: 209857
Active ingredients:
irinotecan hydrochloride trihydrate

Dosage form:
Injection, concentrated

Sponsor:
Accord Healthcare Pty Ltd

Phone:
1800 222 673

From
02 Jun 2025
to
31 Aug 2025

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
An alternative strength is available.

IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 500 mg/25 mL concentrated injection vial
AUST R: 316412
Active ingredients:
irinotecan hydrochloride trihydrate

Dosage form:
Injection, concentrated

Sponsor:
Accord Healthcare Pty Ltd

Phone:
1800 222 673

From
07 Mar 2025
to
15 May 2025

Shortage status:
Resolved

Availability:
Available

Reason:
Manufacturing

MEDITAB IRINOTECAN irinotecan hydrochloride trihydrate 100 mg / 5 mL injection vial
AUST R: 167202
Active ingredients:
irinotecan hydrochloride trihydrate

Dosage form:
Injection

Sponsor:
Cipla Australia Pty Ltd

Phone:
03 9696 4413

Deletion from market:
12 Jun 2025

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Manufacturing

Management action:
An alternative brand is available.